Cover Image

Metastatic Eccrine Porocarcinoma Respond to Combination Chemotherapy Docetaxel, Cisplatin and Infusion 5 FU with Long Disease Control

Hussein Khaled, Rasha Abo EL Hassan

Abstract


Introduction: Eccrine porocarcinoma (EPC) is a rare tumor. It develops from the intraepidermal ductal portion of the eccrine sweat gland. Many chemotherapeutic agents were reported to have efficacy in treatment of metastatic EPC; two of very effective agents were docetaxel and 5FU.

Case Presentation: We are reporting a case of 60 years old female who was diagnosed as metastatic eccrine porocarcinoma to mediastinum which was treated by systemic chemotherapy in the form of DCF: docetaxel 75 mg/m2 D1, cisplatin 75 mg/m2 D1 and continues infusion 5FU 750 mg/m2 from D1 to D4, and this regimen was repeated every 28 days for 6 cycles.

Conclusion: DCF regimen can be one of the best options for stage IV EPC with long overall survival and best response rate.


Keywords


Metastatic Eccrine porocarcinoma; DCF; long disease control

Full Text:

PDF

References


Pinkus H, Mehregan AH: Epidermotropic eccrine carcinoma. Arch Dermatol. 1963;88:597-606

Marone U, Caracò C, Anniciello AM, Di Monta G, Chiofalo MG, Di Cecilia ML, Mozzillo N. Metastatic eccrine porocarcinoma: report of a case and review of the literature. World J Surg Oncol. 2011, 9:32

Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, Calonje E. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol. 2001;25:710-720

Mehregan AH, Hashimoto K, Rahbari H: Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol. 1983, 119:104-114

Sung Hoon Choi, Young Joon Kim, Hoon Kim1, Hyun-Jung Kim, Sang Hyun Nam, Young Woong Choi. Archives of plastic surgery. 2014, 41

Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: clinical and pathological studies of 12 cases. J Dermatol. 2007, 34:516-22

Huet P, Dandurand M, Pignodel C, and Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. Journal of the American Academy of Dermatology. 1996, 35: 860-864

Plunkett TA, Hanby AM, Miles DW, and Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Annals of Oncology. 2001, 12:411-414

Coonley CJ, Kelsen DP, Huvos AG, Schaner P, Sordillo P: Chemotherapy of metastatic sweat gland carcinoma. A retrospective review. Am J Clin Oncol. 1985, 8:307-311


Refbacks

  • There are currently no refbacks.


AJCC-REP (ISSN 2572-5742)Copyright © 2012-2020. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States